Surge Therapeutics
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- surgetx.com
- Total Funding
- $58.0M
- Last Round
- $32.0M Series BJul 2023
About
Develops an injectable intraoperative immunotherapy hydrogel to prevent post-surgical cancer recurrence by locally releasing cancer immunotherapy.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account